幹細胞治療市場規模、佔有率及成長分析（按細胞來源、類型、治療應用和地區）－2025-2032 年產業預測

全球幹細胞治療市場預計到 2023 年將達到 123 億美元，從 2024 年的 140.6 億美元成長到 2032 年的 409.6 億美元，預測期內（2025-2032 年）的複合年成長率為 14.3%。

受癌症等疾病日益流行的推動以及再生醫學的進步，全球幹細胞治療市場正在經歷顯著成長。幹細胞是開發有助於癒合和組織再生的專門細胞的普遍來源，使幹細胞療法成為傳統器官移植的可行替代方案。研究人員正在創新性地培養和改造幹細胞以產生特定細胞，例如心肌或血細胞，從而擴大治療選擇。此外，源自成體組織的誘導誘導性多功能幹細胞的潛力正在支持市場，為治療帶來新的希望。此外，幹細胞移植等治療方法可取代受損細胞，徹底改變血液相關疾病和惡性腫瘤的治療方式，凸顯出巨大的市場潛力。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 專利分析
• 技術分析
• 案例研究

幹細胞治療市場規模：依細胞來源及複合年成長率（2025-2032）

• 市場概覽
• 脂肪組織來源的間質幹細胞
• 骨髓間質間質幹細胞
• 胎盤/臍帶來源的間質幹細胞
• 其他

幹細胞治療市場規模（按類型及複合年成長率）（2025-2032）

• 市場概覽
• 同種異體幹細胞治療
• 自體幹細胞治療

幹細胞治療市場規模：依治療應用及複合年成長率（2025-2032）

• 市場概覽
• 肌肉骨骼疾病
• 傷口和手術
• 發炎與自體免疫疾病
• 再生醫學
• 藥物研發
• 心血管疾病
• 神經系統疾病
• 其他

幹細胞治療市場規模：依地區及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Novartis AG（Switzerland）
• Pfizer Inc.（US）
• Mesoblast Limited（Australia）
• Gamida Cell Ltd.（Israel）
• Vericel Corporation（US）
• Medipost Co., Ltd.（South Korea）
• Astellas Pharma Inc.（Japan）
• Cynata Therapeutics Limited（Australia）
• Lonza Group Ltd.（Switzerland）
• Caladrius Biosciences, Inc.（US）
• Athersys, Inc.（US）
• Cytori Therapeutics, Inc.（US）
• Holostem Terapie Avanzate Srl（Italy）
• Pluristem Therapeutics Inc.（Israel）
• BioTime, Inc.（US）
• Smith+Nephew（UK）
• JCR Pharmaceuticals Co., Ltd.（Japan）
• Anterogen Co., Ltd.（South Korea）
• Corestem, Inc.（South Korea）
• Pharmicell Co., Ltd（South Korea）

結論和建議

Global Stem Cell Therapy Market size was valued at USD 12.3 billion in 2023 and is poised to grow from USD 14.06 billion in 2024 to USD 40.96 billion by 2032, growing at a CAGR of 14.3% during the forecast period (2025-2032).

The global stem cell therapy market is witnessing significant growth, driven by the increasing prevalence of diseases such as cancer and advancements in regenerative medicine. Stem cells serve as a versatile source for developing specialized cells to aid in healing and tissue regeneration, positioning stem cell therapy as a viable alternative to traditional organ transplantation. Researchers are innovatively cultivating and modifying stem cells to create specific cell types, such as heart muscle or blood cells, enhancing treatment options. The market is further supported by the potential of induced pluripotent stem cells derived from adult tissue, promising new avenues in therapy. Additionally, procedures like stem cell transplants, which replace damaged cells, are transforming how blood-related disorders and malignancies are treated, highlighting immense market potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Stem Cell Therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Stem Cell Therapy Market Segments Analysis

Global Stem Cell Therapy Market is segmented by Cell Source, Type, Therapeutic Application and region. Based on Cell Source, the market is segmented into Adipose Tissue-derived Mesenchymal Stem Cells, Bone Marrow-derived Mesenchymal Stem Cells, Placenta/Umbilical Cord-derived Mesenchymal Stem Cells and Other. Based on Type, the market is segmented into Allogeneic Stem Cell Therapy and Autologous Stem Cell Therapy. Based on Therapeutic Application, the market is segmented into Musculoskeletal Disorders, Wounds & Surgeries, Inflammatory & Autoimmune Diseases, Regenerative Medicine, Drug Discovery and Development, Cardiovascular Diseases, Neurological Disorders and Other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Stem Cell Therapy Market

The Global Stem Cell Therapy market is significantly driven by financial support from government agencies and favorable regulatory frameworks that create a supportive environment for research and development in this field. The growing demand for innovative and effective treatment alternatives for autoimmune, neurological, and cardiovascular disorders has led to heightened research initiatives and increased funding for cell-based studies. This emphasis on advancing therapeutic solutions fosters a robust landscape for stem cell research, ultimately enhancing the potential for breakthroughs and improvements in patient care, thus propelling the expansion of the stem cell therapy market on a global scale.

Restraints in the Global Stem Cell Therapy Market

The global stem cell therapy market faces significant challenges primarily due to ethical concerns surrounding the use of embryonic stem cells. These cells are predominantly sourced from human embryos, raising moral issues related to the potential destruction of human life. This ethical dilemma complicates the commercial development of stem cell treatments. Furthermore, the landscape for stem cell research and applications is inconsistent across different regions, influenced by varying regulations and public perceptions. As a result, these factors create a complex environment that hinders advancements and acceptance within the stem cell therapy market.

Market Trends of the Global Stem Cell Therapy Market

The Global Stem Cell Therapy market is witnessing significant growth and transformation, driven by advancements in therapeutic innovations and increased demand for regenerative medicine. Pharmaceutical companies are actively seeking specialized talent with expertise in stem cell research and product development, reflecting a shift towards more complex therapeutic applications. As they explore novel drug delivery systems and expand their product portfolios, collaboration with firms possessing deep knowledge in biological sciences and controlled release methodologies has become paramount. This trend highlights the burgeoning intersection of research and commercialization in stem cell therapies, paving the way for breakthrough treatments and improved patient outcomes in the healthcare sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Patent Analysis
• Technology Analysis
• Case Studies

Global Stem Cell Therapy Market Size by Cell Source & CAGR (2025-2032)

• Market Overview
• Adipose Tissue-derived Mesenchymal Stem Cells
• Bone Marrow-derived Mesenchymal Stem Cells
• Placenta/Umbilical Cord-derived Mesenchymal Stem Cells
• Other

Global Stem Cell Therapy Market Size by Type & CAGR (2025-2032)

• Market Overview
• Allogeneic Stem Cell Therapy
• Autologous Stem Cell Therapy

Global Stem Cell Therapy Market Size by Therapeutic Application & CAGR (2025-2032)

• Market Overview
• Musculoskeletal Disorders
• Wounds & Surgeries
• Inflammatory & Autoimmune Diseases
• Regenerative Medicine
• Drug Discovery and Development
• Cardiovascular Diseases
• Neurological Disorders
• Other

Global Stem Cell Therapy Market Size & CAGR (2025-2032)

• North America (Cell Source, Type, Therapeutic Application)
  • US
  • Canada
• Europe (Cell Source, Type, Therapeutic Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Cell Source, Type, Therapeutic Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Cell Source, Type, Therapeutic Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Cell Source, Type, Therapeutic Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mesoblast Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gamida Cell Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vericel Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medipost Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Astellas Pharma Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cynata Therapeutics Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caladrius Biosciences, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Athersys, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytori Therapeutics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Holostem Terapie Avanzate S.r.l. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pluristem Therapeutics Inc. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioTime, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith+Nephew (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JCR Pharmaceuticals Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anterogen Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corestem, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharmicell Co., Ltd (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations